"Hepatitis B, Chronic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Descriptor ID |
D019694
|
MeSH Number(s) |
C02.256.430.400.100 C02.440.435.100 C06.552.380.350.100 C06.552.380.705.437.100
|
Concept/Terms |
Hepatitis B, Chronic- Hepatitis B, Chronic
- Chronic Hepatitis B
- Hepatitis B Virus Infection, Chronic
- Chronic Hepatitis B Virus Infection
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B, Chronic".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B, Chronic".
This graph shows the total number of publications written about "Hepatitis B, Chronic" by people in this website by year, and whether "Hepatitis B, Chronic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 |
2006 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2011 | 2 | 0 | 2 |
2012 | 2 | 0 | 2 |
2014 | 2 | 0 | 2 |
2017 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis B, Chronic" by people in Profiles.
-
Abara WE, Qaseem A, Schillie S, McMahon BJ, Harris AM. Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2017 Dec 05; 167(11):794-804.
-
Hawkins C, Christian B, Fabian E, Macha I, Gawile C, Mpangala S, Ulenga N, Thio CL, Ammerman LR, Mugusi F, Fawzi W, Green R, Murphy R. Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults. . 2017 11 01; 76(3):298-302.
-
Wan S, Hann HW, Ye Z, Hann RS, Lai Y, Wang C, Li L, Myers RE, Li B, Xing J, Yang H. Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients. Carcinogenesis. 2017 Apr 01; 38(4):439-446.
-
Halegoua-De Marzio D, Hann HW. Prevention of hepatocellular carcinoma and its recurrence with anti-hepatitis B viral therapy. Minerva Gastroenterol Dietol. 2014 Sep; 60(3):191-200.
-
Halegoua-De Marzio D, Hann HW. Then and now: the progress in hepatitis B treatment over the past 20 years. World J Gastroenterol. 2014 Jan 14; 20(2):401-13.
-
Juon HS, Park BJ. Effectiveness of a culturally integrated liver cancer education in improving HBV knowledge among Asian Americans. Prev Med. 2013 Jan; 56(1):53-8.
-
Fu X, Wan S, Hann HW, Myers RE, Hann RS, Au J, Chen B, Xing J, Yang H. Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection. Eur J Cancer. 2012 May; 48(7):1014-22.
-
Zhao S, Yang Y, Liu J, Liu H, Ge N, Yang H, Zhang H, Xing J. Association of mitochondrial DNA content in peripheral blood leukocyte with hepatitis B virus-related hepatocellular carcinoma in a Chinese Han population. Cancer Sci. 2011 Aug; 102(8):1553-8.
-
Hann HW, Bergin D, Coben R, DiMarino AJ. Prevention of new hepatocellular carcinoma with concomitant antiviral therapy in chronic hepatitis B patients whose initial tumor was successfully ablated. Int J Cancer. 2011 Feb 1; 128(3):739-42.
-
van den Berg-Wolf M, Tedaldi EM. Therapeutic strategies for chronic hepatitis B virus infection in 2008-optimum dosing lamivudine challenged for HIV-1 infected patients. Am J Med. 2009 Aug; 122(8):e11.